Property:Type of measurement
Appearance
This is a property of type Text.
The allowed values for this property are:
- AQoL-8D (Assessment of Quality of Life)
- ASAT (Auditory Sustained Attention Test)
- Atomic absorption
- Audiogram
- AUSCAN (Australian/Canadian Osteoarthritis Hand Index)
- BFI (Brief Fatigue Inventory)
- BIA (Bioelectrical impedance analysis)
- Blood Test
- BCPT (Breast Cancer Prevention Symptom Scales)
- BDI (Beck Depression Inventory)
- BPI-SF (Brief Pain Inventory - Short Form)
- CES-D (Center for Epidemiologic Studies - Depression Scale)
- Chemiluminescent immunoassay
- CNPI (Checklist of Non-Verbal Pain Indicators)
- CSSP (Catterall Skin Scoring Profile)
- CT (Computed Tomography)
- CTCAE (Common Terminology Criteria of Adverse Events)
- Cystoscopy
- Diary questionnaire
- DXA (Dual energy X-ray Absorptiometry)
- Dynamometer
- Echo-color Doppler
- ECOG Performance Status Scale (Eastern Cooperative Oncology Group)
- Electronic monitoring device
- Electrophysiological evaluation
- ELISA protocol (Enzyme-Linked Immunoabsorbent Assay)
- EORTC QLQ (European Organisation for Research and Treatment of Cancer Core/ Quality of Life questionnaire)
- EQ-5D (European Quality of Life 5 Dimensions)
- ESAS (Edmonton Symptom Assessment Scale)
- FAACT (Functional Assessment of Anorexia-Cachexia Therapy)
- FACIT (Functional Assessment of Chronic Illness Therapy)
- FACT (Functional Assessment of Cancer Therapy)
- FGS (Hughes' Functional Grading Scale)
- FIQ (Fibromyalgia Impact Questionnaire)
- FLIE (Functional Living Index for Emesis)
- Genitourinary atrophy self-assessment tool
- GFAAS (Graphite Furnace Atomic Absorption Spectrometry)
- Global Charter Fatigue Scale
- GPS (Glasgow Prognostic Score)
- HADS (Hospital Anxiety and Depression Scale)
- HAQ-DI (Health Assessment Questionnaire-Disability Index)
- HFRDIS (Hot Flash Related Daily Interference Scale)
- HFS (Hot Flush Score)
- HGST Maximum (Handgrip Strength Test)
- Histological examination
- HNQR (Head and Neck Radiotherapy Questionnaire)
- HSCS (High Sensitivity Cognitive Screen)
- ICI Test (Intracavernosal Injection Test)
- IIEF (International Index of Erectile Function)
- Indirect calorimetry
- Interview
- KPS (Karnofsky Performance Status)
- LASA (Linear Analogue Self-Assessment)
- LENT SOMA Scale (Late Effects on Normal Tissues/ Subjective Objective Management Analysis)
- MADRS (Montgomery-Asberg Depression Rating Scale)
- MAT (Multinational Association of Supportive Care in Cancer-Antiemesis Tool)
- McDonald criteria
- MDASI (M. D. Anderson Symptom Inventory)
- Measuring tape
- MENQOL (Menopause-Specific Quality of Life)
- MFI-20 (Multidimensional Fatigue Inventory-20)
- MFSI (Multidimensional Fatigue Symptom Inventory)
- MMSE (Mini-Mental State Exam)
- Morbidity rating scale (by Dische)
- MOS SF-12 (Medical Outcomes Study/ 12-Item Short Form Health Survey)
- MPQ-SF (McGill Pain Questionnaire - Short Form)
- MRI (Magnetic Resonance Imaging)
- MRS (Mood Rating Scale)
- MYCaW (Measure Yourself Concerns and Wellbeing)
- NCI-CTC v.2 (National Cancer Institute-Common Toxic Criteria)
- NCI Grading Scale (National Cancer Institute)
- NDS (Neurological Disability Score)
- Neurologic examination
- Neuropathy specific question
- NRS (Numeric Rating Scale)
- NRS (Nutritional Risk Screening)
- NSS (Neurological Symptom Score)
- Observation
- OMAS (Oral Mucositis Assessment Scale)
- Otoacoustic Emissions Testing
- PAC-QoL (Patient Assessment of Constipation - Quality of Life)
- PGIC (Physician Global Impression of Change)
- PG-SGA (Patient-Generated Subjective Global Assessment)
- PHLF (Post Hepatectomy Liver Failure)
- PHS (Cognitive subscale of the Perceived Health Scale)
- pH-value
- Physical examination
- Physical functioning (grip strength;6 minute walk;leg extension)
- POMS (Profile of Mood States)
- PoSSe (Postoperative Symptom Severity Scale)
- Postoperative morbidity/ complications (classification according to Clavien-Dindo)
- PROMIS (Patient-Reported Outcomes Measurement Information System)
- PSQ (Patient Satisfaction Questionnaire)
- PSQI (Pittsburgh Sleep Quality Index)
- QoR-40 (Quality of Recovery-40 Questionnaire)
- RDS (Radiation Dermatitis Severity)
- RECIST 1.0 Criteria (Response Evaluation Criteria in Solid Tumors)
- Reidel-Seiffer tuning fork
- Rhodes Inventory of Nausea
- RPSAS (Radiation Proctopathy System Assessment Scale)
- RTOG Acute Radiation Morbidity Scoring Criteria (Radiation Therapy Oncology Group)
- Scale
- SCID (Structured Clinical Interview for DSM IV)
- Scintigraphy
- Self-developed measurement instrument
- SF-36 (Short Form-36 Health Survey)
- SF-MPQ (Short-Form McGill Pain Questionnaire)
- SGIC (Subject Global Impression of Change)
- SI (Symptom Inventory questionnaire)
- SOMA (Subjective Objective Medical management and Analytic evaluation of injury)
- SPECT (Single Photon Emission Computed Tomography)
- Spectrophotometry
- SPPB (Short Physical Performance Battery)
- STAI (State-Trait-Anxiety-Inventory)
- Symptom experience diary (NCCTG)
- Thermometer
- Three-stimulus drop technique (by Henkin)
- Tissue testing
- TMT (Trail Making Test)
- TNS (Total Neuropathy Score)
- Toxicity criteria of RTOG (Radiation Therapy Oncology Group) and EORTC (European Organization for Research and Treatment of Cancer)
- Ultrasonography
- Unspecified questionnaire
- Urinalysis
- VAS (Visual Analogue Scale)
- VMI (Vaginal Maturation Index)
- VNS (Verbal Numerical Scale)
- Volometer
- Western Ontario and McMaster Osteoarthritis Index
- WHO-Scale (World Health Organisation)
- Wound volume
- NI
- NA
- ?
A
Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients +
NI +
Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients +
NI +
Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer +
Observation +
Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer +
Blood Test +
Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer +
Observation +
Attia et al. (2008): Randomized, Double-Blinded Phase II Evaluation of Docetaxel with or without Doxercalciferol in Patients with Metastatic, Androgen-Independent Prostate Cancer +
WHO-Scale (World Health Organisation) +
Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis +
VAS (Visual Analogue Scale) +
Azizi et al. (2015): Efficacy of Topical and Systemic Vitamin E in Preventing Chemotherapy-induced Oral Mucositis +
WHO-Scale (World Health Organisation) +
B
Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients +
Observation +
Bairati et al. (2005): A Randomized Trial of Antioxidant Vitamins to Prevent Second Primary Cancers in Head and Neck Cancer Patients +
Observation +
Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients +
Observation +
Bairati et al. (2005): Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients +
RTOG Acute Radiation Morbidity Scoring Criteria (Radiation Therapy Oncology Group) +
Bairati et al. (2006): Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients +
Observation +
Barton et al. (1998): Prospective evaluation of vitamin E for hot flashes in breast cancer survivors +
Diary questionnaire +
Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 +
NCI-CTC v.2 (National Cancer Institute-Common Toxic Criteria) +
Beer et al. (2007): Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators +
RECIST 1.0 Criteria (Response Evaluation Criteria in Solid Tumors) +
{ "type": "PROPERTY_CONSTRAINT_SCHEMA", "constraints": { "type_constraint": "_txt", "allowed_values": [ "AQoL-8D (Assessment of Quality of Life)", "ASAT (Auditory Sustained Attention Test)", "BIA (Bioelectrical impedance analysis)", "BPI-SF (Brief Pain Inventory - Short Form)", "CTCAE (Common Terminology Criteria of Adverse Events)", "ESAS (Edmonton Symptom Assessment Scale)", "FAACT (Functional Assessment of Anorexia-Cachexia Therapy)", "FACIT (Functional Assessment of Chronic Illness Therapy)", "FLIE (Functional Living Index for Emesis)", "Genitourinary atrophy self-assessment tool", "HADS (Hospital Anxiety and Depression Scale)", "HFRDIS (Hot Flash Related Daily Interference Scale)", "HFS (Hot Flush Score)", "MADRS (Montgomery-Asberg Depression Rating Scale)", "MFI-20 (Multidimensional Fatigue Inventory-20)", "NRS (Numeric Rating Scale)", "NRS (Nutritional Risk Screening)", "pH-value", "Postoperative morbidity/ complications (classification according to Clavien-Dindo)", "QoR-40 (Quality of Recovery-40 Questionnaire)", "SF-36 (Short Form-36 Health Survey)", "SPPB (Short Physical Performance Battery)", "VAS (Visual Analogue Scale)", "VMI (Vaginal Maturation Index)", "Wound volume", "?", "NI", "Physical functioning (grip strength;6 minute walk;leg extension)", "Blood Test", "ECOG Performance Status Scale (Eastern Cooperative Oncology Group)", "ELISA protocol (Enzyme-Linked Immunoabsorbent Assay)", "GFAAS (Graphite Furnace Atomic Absorption Spectrometry)", "Observation", "RECIST 1.0 Criteria (Response Evaluation Criteria in Solid Tumors)", "BFI (Brief Fatigue Inventory)", "EORTC QLQ (European Organisation for Research and Treatment of Cancer Core/ Quality of Life questionnaire)", "LENT SOMA Scale (Late Effects on Normal Tissues/ Subjective Objective Management Analysis)", "MOS SF-12 (Medical Outcomes Study/ 12-Item Short Form Health Survey)", "OMAS (Oral Mucositis Assessment Scale)", "RPSAS (Radiation Proctopathy System Assessment Scale)", "RTOG Acute Radiation Morbidity Scoring Criteria (Radiation Therapy Oncology Group)", "Spectrophotometry", "WHO-Scale (World Health Organisation)", "MAT (Multinational Association of Supportive Care in Cancer-Antiemesis Tool)", "Atomic absorption", "FACT (Functional Assessment of Cancer Therapy)", "LASA (Linear Analogue Self-Assessment)", "McDonald criteria", "MRI (Magnetic Resonance Imaging)", "NCI-CTC v.2 (National Cancer Institute-Common Toxic Criteria)", "SPECT (Single Photon Emission Computed Tomography)", "Three-stimulus drop technique (by Henkin)", "AUSCAN (Australian/Canadian Osteoarthritis Hand Index)", "BCPT (Breast Cancer Prevention Symptom Scales)", "Chemiluminescent immunoassay", "Diary questionnaire", "DXA (Dual energy X-ray Absorptiometry)", "Electrophysiological evaluation", "FGS (Hughes' Functional Grading Scale)", "FIQ (Fibromyalgia Impact Questionnaire)", "HAQ-DI (Health Assessment Questionnaire-Disability Index)", "HGST Maximum (Handgrip Strength Test)", "Histological examination", "MENQOL (Menopause-Specific Quality of Life)", "NDS (Neurological Disability Score)", "NSS (Neurological Symptom Score)", "Scintigraphy", "SOMA (Subjective Objective Medical management and Analytic evaluation of injury)", "Ultrasonography", "Western Ontario and McMaster Osteoarthritis Index", "PROMIS (Patient-Reported Outcomes Measurement Information System)", "VNS (Verbal Numerical Scale)", "Audiogram", "Cystoscopy", "Dynamometer", "HSCS (High Sensitivity Cognitive Screen)", "NCI Grading Scale (National Cancer Institute)", "Neurologic examination", "Neuropathy specific question", "PHLF (Post Hepatectomy Liver Failure)", "PHS (Cognitive subscale of the Perceived Health Scale)", "POMS (Profile of Mood States)", "Reidel-Seiffer tuning fork", "Scale", "TMT (Trail Making Test)", "TNS (Total Neuropathy Score)", "Urinalysis", "HNQR (Head and Neck Radiotherapy Questionnaire)", "CES-D (Center for Epidemiologic Studies - Depression Scale)", "Echo-color Doppler", "Global Charter Fatigue Scale", "ICI Test (Intracavernosal Injection Test)", "IIEF (International Index of Erectile Function)", "Interview", "KPS (Karnofsky Performance Status)", "MMSE (Mini-Mental State Exam)", "MPQ-SF (McGill Pain Questionnaire - Short Form)", "Otoacoustic Emissions Testing", "PSQI (Pittsburgh Sleep Quality Index)", "RDS (Radiation Dermatitis Severity)", "SI (Symptom Inventory questionnaire)", "Symptom experience diary (NCCTG)", "NA", "Self-developed measurement instrument", "CT (Computed Tomography)", "EQ-5D (European Quality of Life 5 Dimensions)", "GPS (Glasgow Prognostic Score)", "MFSI (Multidimensional Fatigue Symptom Inventory)", "Toxicity criteria of RTOG (Radiation Therapy Oncology Group) and EORTC (European Organization for Research and Treatment of Cancer)", "Indirect calorimetry", "PAC-QoL (Patient Assessment of Constipation - Quality of Life)", "PGIC (Physician Global Impression of Change)", "PG-SGA (Patient-Generated Subjective Global Assessment)", "PoSSe (Postoperative Symptom Severity Scale)", "PSQ (Patient Satisfaction Questionnaire)", "Rhodes Inventory of Nausea", "SGIC (Subject Global Impression of Change)", "Volometer", "Electronic monitoring device", "Measuring tape", "Physical examination", "Thermometer", "Unspecified questionnaire", "BDI (Beck Depression Inventory)", "CSSP (Catterall Skin Scoring Profile)", "Morbidity rating scale (by Dische)", "Tissue testing", "CNPI (Checklist of Non-Verbal Pain Indicators)", "MDASI (M. D. Anderson Symptom Inventory)", "MRS (Mood Rating Scale)", "MYCaW (Measure Yourself Concerns and Wellbeing)", "SCID (Structured Clinical Interview for DSM IV)", "SF-MPQ (Short-Form McGill Pain Questionnaire)", "STAI (State-Trait-Anxiety-Inventory)" ] } }